Euglena Co., Ltd. (TYO:2931)

Market Cap	52.78B -20.5%
Revenue (ttm)	50.37B +5.8%
Net Income	-805.00M
EPS	-5.90
Shares Out	139.25M
PE Ratio	n/a
Forward PE	135.36
Dividend	2.00 (0.55%)
Ex-Dividend Date	Dec 29, 2025

Volume	1,289,500
Average Volume	1,477,560
Open	375.00
Previous Close	369.00
Day's Range	371.00 - 382.00
52-Week Range	356.00 - 540.00
Beta	-0.11
RSI	44.14
Earnings Date	May 14, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, and midori koji; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorpor...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 897
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.